Reduced expression of L-selectin in T-cells correlates with relative lymphocyte increase in patients with RRMS treated with natalizumab - functional implication towards PML risk. Επικοινωνία Submitted by Δημήτρης Σπάχος on Παρ, 12/04/2020 - 16:24
